{"entity":{"type":"insider","cik":"0001486429","url":"/insider/0001486429","json_url":"/insider/0001486429.json","name":"Ezickson Elan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2010-10-05","last":"2025-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Ezickson Elan","source":"filing","n_filings":14,"first_seen":"2010-10-05","last_seen":"2025-01-23"}],"transactions":[{"id":5122168,"accession":"0001415889-25-001930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-001930","line_url":"/filing/0001415889-25-001930#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":864.0,"total_display":"864.00","total_whole":"864","shares_owned_after":10900.0,"shares_owned_after_display":"10,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":8516009,"accession":"0001415889-23-002162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-002162","line_url":"/filing/0001415889-23-002162#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":6.56,"price_display":"6.56","price_state":"stated","total_value":4920.0,"total_display":"4,920.00","total_whole":"4,920","shares_owned_after":5600.0,"shares_owned_after_display":"5,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":5387136,"accession":"0001181431-13-005181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-005181","line_url":"/filing/0001181431-13-005181#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1150.0,"shares_display":"1,150","price_per_share":7.7711,"price_display":"7.77","price_state":"stated","total_value":8936.765,"total_display":"8,936.76","total_whole":"8,937","shares_owned_after":61843.0,"shares_owned_after_display":"61,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-28","scope":"insider"},{"id":3372509,"accession":"0001181431-12-004431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-004431","line_url":"/filing/0001181431-12-004431#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1107.0,"shares_display":"1,107","price_per_share":13.3658,"price_display":"13.37","price_state":"stated","total_value":14795.9406,"total_display":"14,795.94","total_whole":"14,796","shares_owned_after":4893.0,"shares_owned_after_display":"4,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-30","scope":"insider"},{"id":9188093,"accession":"0001181431-11-036548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-036548","line_url":"/filing/0001181431-11-036548#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.7306,"price_display":"18.73","price_state":"stated","total_value":187306.0,"total_display":"187,306.00","total_whole":"187,306","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-10","filed_date":"2011-06-14","scope":"insider"},{"id":9188006,"accession":"0001181431-11-030479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-030479","line_url":"/filing/0001181431-11-030479#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.0774,"price_display":"18.08","price_state":"stated","total_value":180774.0,"total_display":"180,774.00","total_whole":"180,774","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-17","scope":"insider"},{"id":8964274,"accession":"0001181431-11-023871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-023871","line_url":"/filing/0001181431-11-023871#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.627,"price_display":"13.63","price_state":"stated","total_value":136270.0,"total_display":"136,270.00","total_whole":"136,270","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-13","scope":"insider"},{"id":8842558,"accession":"0001181431-11-019049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-019049","line_url":"/filing/0001181431-11-019049#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":14.4175,"price_display":"14.42","price_state":"stated","total_value":108131.25,"total_display":"108,131.25","total_whole":"108,131","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-16","filed_date":"2011-03-18","scope":"insider"},{"id":9160411,"accession":"0001181431-11-012429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-012429","line_url":"/filing/0001181431-11-012429#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.8529,"price_display":"13.85","price_state":"stated","total_value":69264.5,"total_display":"69,264.50","total_whole":"69,265","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-22","filed_date":"2011-02-23","scope":"insider"},{"id":8902441,"accession":"0001181431-11-003371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-003371","line_url":"/filing/0001181431-11-003371#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.7748,"price_display":"14.77","price_state":"stated","total_value":73874.0,"total_display":"73,874.00","total_whole":"73,874","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-10","filed_date":"2011-01-13","scope":"insider"},{"id":9251973,"accession":"0001181431-11-019048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-019048","line_url":"/filing/0001181431-11-019048#line-1","is_derivative":false,"issuer_cik":"0001486429","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001486429","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":14.279,"price_display":"14.28","price_state":"stated","total_value":35697.5,"total_display":"35,697.50","total_whole":"35,698","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-10","filed_date":"2011-03-18","scope":"insider"},{"id":7410189,"accession":"0001181431-10-061112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-061112","line_url":"/filing/0001181431-10-061112","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.279,"price_display":"14.28","price_state":"stated","total_value":71395.0,"total_display":"71,395.00","total_whole":"71,395","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-10","filed_date":"2010-12-13","scope":"insider","n_lines":2},{"id":7303789,"accession":"0001181431-10-055393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-055393","line_url":"/filing/0001181431-10-055393#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.33,"price_display":"16.33","price_state":"stated","total_value":81650.0,"total_display":"81,650.00","total_whole":"81,650","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-10","filed_date":"2010-11-12","scope":"insider"},{"id":7265738,"accession":"0001181431-10-049837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-049837","line_url":"/filing/0001181431-10-049837#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486429","owner_name":"Ezickson Elan","owner_display_name":"Ezickson Elan","owner_url":"/insider/0001486429","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.0659,"price_display":"13.07","price_state":"stated","total_value":65329.5,"total_display":"65,329.50","total_whole":"65,330","shares_owned_after":45000.0,"shares_owned_after_display":"45,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-04","filed_date":"2010-10-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS, INC.","url":"/issuer/0001267813","role":"Director","n_filings":2,"first_seen":"2023-02-08","last_seen":"2025-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Officer (Chief Operating Officer)","n_filings":12,"first_seen":"2010-10-05","last_seen":"2013-01-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001486429","retrieved_at":"2026-08-22T10:04:28+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}